HRP20171388T1 - Vezna domena bakterijske atp sintaze - Google Patents

Vezna domena bakterijske atp sintaze

Info

Publication number
HRP20171388T1
HRP20171388T1 HRP20171388TT HRP20171388T HRP20171388T1 HR P20171388 T1 HRP20171388 T1 HR P20171388T1 HR P20171388T T HRP20171388T T HR P20171388TT HR P20171388 T HRP20171388 T HR P20171388T HR P20171388 T1 HRP20171388 T1 HR P20171388T1
Authority
HR
Croatia
Prior art keywords
binding domain
atp synthase
bacterial atp
synthase binding
bacterial
Prior art date
Application number
HRP20171388TT
Other languages
English (en)
Inventor
K.J.L.M. Andries
Hinrich W.H. GÖHLMANN
J.-M.E.F.M. Neefs
Peter K.M. Verhasselt
Johann Winkler
Marc René de Jonge
Lucien Maria Henricus Koymans
Original Assignee
Janssen Pharmaceutica N.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica N.V. filed Critical Janssen Pharmaceutica N.V.
Publication of HRP20171388T1 publication Critical patent/HRP20171388T1/hr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/52—Genes encoding for enzymes or proenzymes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/35—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Mycobacteriaceae (F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physics & Mathematics (AREA)
  • Urology & Nephrology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Plant Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Epidemiology (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
HRP20171388TT 2004-09-28 2017-09-14 Vezna domena bakterijske atp sintaze HRP20171388T1 (hr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP04104720 2004-09-28
US62050004P 2004-10-20 2004-10-20
PCT/EP2005/054893 WO2006035051A1 (en) 2004-09-28 2005-09-28 A bacterial atp synthase binding domain
EP05794520.6A EP1797115B1 (en) 2004-09-28 2005-09-28 A bacterial atp synthase binding domain

Publications (1)

Publication Number Publication Date
HRP20171388T1 true HRP20171388T1 (hr) 2017-11-03

Family

ID=38965678

Family Applications (1)

Application Number Title Priority Date Filing Date
HRP20171388TT HRP20171388T1 (hr) 2004-09-28 2017-09-14 Vezna domena bakterijske atp sintaze

Country Status (25)

Country Link
US (2) US8088891B2 (hr)
EP (1) EP1797115B1 (hr)
JP (2) JP2008515395A (hr)
KR (1) KR101539021B1 (hr)
CN (1) CN101065397B (hr)
AU (2) AU2005288848A1 (hr)
CA (1) CA2579971C (hr)
CY (1) CY1119568T1 (hr)
DK (1) DK1797115T3 (hr)
ES (1) ES2636980T3 (hr)
HK (1) HK1114619A1 (hr)
HR (1) HRP20171388T1 (hr)
HU (1) HUE033609T2 (hr)
IL (1) IL182185A (hr)
LT (1) LT1797115T (hr)
ME (1) ME02935B (hr)
NO (1) NO342699B1 (hr)
NZ (1) NZ553693A (hr)
PL (1) PL1797115T3 (hr)
PT (1) PT1797115T (hr)
RS (1) RS56357B1 (hr)
RU (1) RU2418001C2 (hr)
SI (1) SI1797115T1 (hr)
WO (1) WO2006035051A1 (hr)
ZA (1) ZA200702540B (hr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2440736A (en) * 2006-08-10 2008-02-13 Medical Res Council Crystals of mutant p53 polypeptidtes
JO2685B1 (en) 2006-12-06 2013-03-03 جانسين فارماسوتيكا ان في Quinoline antibacterial derivatives
JO3271B1 (ar) 2006-12-06 2018-09-16 Janssen Pharmaceutica Nv مشتقات الكوينولين المضادة للجراثيم
JO2970B1 (en) 2006-12-06 2016-03-15 جانسين فارماسوتيكا ان. في Quinoline antibacterial derivatives
WO2013160431A1 (en) 2012-04-27 2013-10-31 Janssen Pharmaceutica Nv Antibacterial quinoline derivatives
DK2841425T3 (en) 2012-04-27 2016-06-27 Janssen Pharmaceutica Nv ANTIBACTERIAL QUINOLIN DERIVATIVES
US8454434B1 (en) * 2012-06-15 2013-06-04 Igt Gaming system and method for providing an offer and acceptance game with progressive awards associated with a quantity of progressive tokens
JP5580383B2 (ja) 2012-10-05 2014-08-27 株式会社 資生堂 美容機器及び通電方法及び記録媒体
KR101522087B1 (ko) * 2013-06-19 2015-05-28 삼성에스디에스 주식회사 미스매치를 고려한 염기 서열 정렬 시스템 및 방법
CN110373399B (zh) * 2019-07-09 2021-05-28 湖南省植物保护研究所 一种沼泽红假单胞菌Atps2蛋白及其制备方法和应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2119556C (en) 1991-11-01 2004-07-06 Michael Robert Barbachyn Substituted aryl- and heteroaryl-phenyloxazolidinones
US6583266B1 (en) * 1993-08-19 2003-06-24 Genome Therapeutics Corporation Nucleic acid and amino acid sequences relating to mycobacterium tuberculosis and leprae for diagnostics and therapeutics
MXPA02010989A (es) * 2000-05-19 2003-03-10 Genetics Inst Estructuras cristalinas de complejos de p-selectina, ep0105895-selectina, y usos de esta.
WO2002024893A2 (en) * 2000-09-19 2002-03-28 Chiron Corporation CHARACTERIZATION OF THE GSK-3β PROTEIN AND METHODS OF USE THEREOF
AU2002306849A1 (en) * 2001-03-21 2002-10-08 Elitra Pharmaceuticals, Inc. Identification of essential genes in microorganisms
WO2003041715A1 (en) 2001-11-13 2003-05-22 3-Dimensional Pharmaceuticals, Inc. Substituted 1,4-benzodiazepines and uses thereof for the treatment of cancer
SI2301544T1 (sl) * 2002-07-25 2013-01-31 Janssen Pharmaceutica, N.V. Derivati kinolina kot vmesne spojine za mikobakterijske inhibitorje
AU2002951853A0 (en) * 2002-10-04 2002-10-24 Commonwealth Scientific And Industrial Research Organisation Crystal structure of erbb2 and uses thereof

Also Published As

Publication number Publication date
DK1797115T3 (en) 2017-10-02
US20090298874A1 (en) 2009-12-03
US8088891B2 (en) 2012-01-03
JP5837852B2 (ja) 2015-12-24
RS56357B1 (sr) 2017-12-29
LT1797115T (lt) 2017-10-10
RU2007116144A (ru) 2008-11-10
PT1797115T (pt) 2017-08-29
SI1797115T1 (sl) 2017-10-30
CN101065397A (zh) 2007-10-31
KR101539021B1 (ko) 2015-07-23
CA2579971A1 (en) 2006-04-06
ES2636980T3 (es) 2017-10-10
HUE033609T2 (en) 2017-12-28
EP1797115B1 (en) 2017-06-21
ZA200702540B (en) 2008-08-27
CN101065397B (zh) 2015-10-21
KR20070073823A (ko) 2007-07-10
CA2579971C (en) 2018-02-13
JP2012210210A (ja) 2012-11-01
AU2012216368A1 (en) 2012-09-13
EP1797115A1 (en) 2007-06-20
CY1119568T1 (el) 2018-03-07
US20120219964A1 (en) 2012-08-30
AU2012216368B2 (en) 2017-04-13
HK1114619A1 (zh) 2008-11-07
WO2006035051A1 (en) 2006-04-06
IL182185A0 (en) 2007-07-24
US8378085B2 (en) 2013-02-19
NO20072237L (no) 2007-06-25
JP2008515395A (ja) 2008-05-15
ME02935B (me) 2018-04-20
NO342699B1 (no) 2018-07-09
PL1797115T3 (pl) 2017-12-29
RU2418001C2 (ru) 2011-05-10
AU2005288848A1 (en) 2006-04-06
IL182185A (en) 2017-12-31
NZ553693A (en) 2012-05-25

Similar Documents

Publication Publication Date Title
HRP20171388T1 (hr) Vezna domena bakterijske atp sintaze
PL1866551T3 (pl) Wkładka łącząca
EP1883627A4 (en) BIRTH DOMAIN BINDER COMPOUNDS
ZA200809733B (en) Iap bi domain binding compounds
EP1908601A4 (en) BINDING DEVICE
EP1908602A4 (en) BINDING DEVICE
GB0520523D0 (en) Object binding
GB2453894B (en) Binding assembly
EP1961716A4 (en) BINDER
GB0410627D0 (en) Specific binding members
GB2432538B (en) Ball-game training aid
GB0400649D0 (en) Insert
GB2433914B (en) Book binding
ZA200610625B (en) A putting aid
GB0618070D0 (en) Low cost flipbook
AU3229P (en) Lusa Trifolium resupinatum
GB0511152D0 (en) Music aid
GB0520934D0 (en) Object binding
GB0525885D0 (en) Object binding
GB0623233D0 (en) Leaf prodder
PL115567U1 (en) A mug
AU2005903129A0 (en) Cover for a soft furnishing item
GB0519212D0 (en) A training aid
AU2006903332A0 (en) Cover For a Soft Furnishing Item
PL372549A1 (en) Fireplace insert